Inquiry Basket
Fmoc-D-Trp(Boc)-OH is a key linker in the field of antibody-conjugated drug development and is widely used in the synthesis of a variety of drugs to treat a variety of diseases. It is indispensable in facilitating the production of drugs that precisely target designated receptors and enzymes implicated in neurological diseases, inflammation, and oncological malignancies.
| Catalog Number | Size | Price | Quantity | ||
|---|---|---|---|---|---|
| BADC-01505 | -- | $-- | Inquiry |
Fmoc-D-Trp(Boc)-OH, a derivative of the amino acid tryptophan, is an essential component in peptide chemistry, particularly in the realm of drug discovery. The molecule is characterized by the presence of the fluorenylmethyloxycarbonyl (Fmoc) group and a tert-butoxycarbonyl (Boc) group, which serve as protective groups during peptide synthesis. This chemical architecture not only provides stability but also enhances the molecule’s suitability for targeted drug development. The Fmoc group is critical in facilitating the stepwise synthesis of peptides, and its compatibility with solid-phase synthesis methods makes it highly desirable for generating complex molecular structures.
In the context of drug discovery, Fmoc-D-Trp(Boc)-OH is primarily utilized as a linker in antibody-drug conjugates (ADCs). These ADCs are instrumental in treating a variety of diseases by linking a biologically active drug to an antibody that specifically targets cancer cells. The unique properties of Fmoc-D-Trp(Boc)-OH, including its ability to form stable linkages and undergo controlled cleavage, enable the precise delivery of therapeutic agents directly to diseased cells, minimizing the impact on healthy tissues. This specificity not only boosts the efficacy of drugs but also significantly reduces their side effects, which is a crucial advantage in oncology therapeutics.
Moreover, Fmoc-D-Trp(Boc)-OH’s role extends beyond oncology. It is also pivotal in creating drugs targeting neurological diseases and inflammation by aiding the development of biologics that can modulate specific receptors and enzymes. In neurological disorders, where precise targeting of neuronal receptors is required, the reliable linkage and controlled release provided by Fmoc-D-Trp(Boc)-OH facilitate the development of therapies that can cross the blood-brain barrier efficiently, offering new hope in treating conditions such as Alzheimer’s and Parkinson’s diseases.
In inflammatory diseases, the molecule’s ability to assist in the synthesis of peptides that can interfere with specific biochemical pathways is invaluable. By enabling the creation of targeted therapies, Fmoc-D-Trp(Boc)-OH helps in developing drugs that can modulate immune responses with greater accuracy. This precision in modulating biological pathways aids in discovering drugs that not only provide symptomatic relief but also alter disease progression through targeted intervention at the molecular level.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
